| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/05/2001 | EP1130394A1 In vitro models of CNS function and dysfunction |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1130031A1 Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity |
| 09/05/2001 | EP1130020A1 Tropane-derivatives, their preparation and use |
| 09/05/2001 | EP1130017A2 Azole derivatives and their use as superoxide radical inhibitors |
| 09/05/2001 | EP1129711A2 Pinolenic acid against diabetes |
| 09/05/2001 | EP1129710A2 Method for treating migraine symptoms with ibuprofen and salts thereof |
| 09/05/2001 | EP1129708A1 Use of sertraline to treat social phobia |
| 09/05/2001 | EP1129706A2 Use of cGMP PDE5 inhibitors for the treatment of neuropathy |
| 09/05/2001 | EP1129204A1 Novel system for regulating transgene expression |
| 09/05/2001 | EP1129199A2 Cell signaling polypeptides and nucleic acids |
| 09/05/2001 | EP1129191A1 Methods of diagnosing or treating neurological diseases |
| 09/05/2001 | EP1129189A2 Human cell surface receptor proteins |
| 09/05/2001 | EP1129188A1 Pge synthase and methods and means for modulating its activity |
| 09/05/2001 | EP1129183A2 Human glycine transporter type 2 |
| 09/05/2001 | EP1129181A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 09/05/2001 | EP1129108A1 Caspases and apoptosis |
| 09/05/2001 | EP1129097A1 Novel type condensed pyridazinone compounds |
| 09/05/2001 | EP1129096A2 Crf receptor antagonists and methods relating thereto |
| 09/05/2001 | EP1129094A2 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
| 09/05/2001 | EP1129091A2 Crf receptor antagonists and methods relating thereto |
| 09/05/2001 | EP1129090A1 PENTAAZA-CYCLOPENTA A]NAPHTHALENE DERIVATIVES AS LIGANDS FOR GABA A? $g(a)5 RECEPTORS |
| 09/05/2001 | EP1129089A1 Spiro-indolines as y5 receptor antagonists |
| 09/05/2001 | EP1129086A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 09/05/2001 | EP1129078A2 Indazole derivatives with 5-ht2 receptor activity |
| 09/05/2001 | EP1129077A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 09/05/2001 | EP1129072A2 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands |
| 09/05/2001 | EP1129070A1 Neurotrophic diamide and carbamate agents |
| 09/05/2001 | EP1128833A1 Use of agonists of glucocorticosteroid receptors and/or mineral corticosteroid receptors, especially corticosteroids to treat addictions |
| 09/05/2001 | EP1128829A1 Riluzole and alpha-tocopherol combination |
| 09/05/2001 | EP1128826A1 Chromone enteric release formulation |
| 09/05/2001 | EP1128825A1 A new composition |
| 09/05/2001 | EP1128814A1 Aerosols comprising nanoparticle drugs |
| 09/05/2001 | EP1128813A1 An inhalation system |
| 09/05/2001 | EP1059889A4 Treatment of brain edema using carbonic anhydrase enzyme inhibitor |
| 09/05/2001 | EP0959888B1 Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease |
| 09/05/2001 | EP0944612B1 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 09/05/2001 | EP0873304B1 Metalloproteinase inhibitors |
| 09/05/2001 | EP0801527A4 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
| 09/05/2001 | EP0792160B1 Glial derived neurotrophic factor as a neuroprotective agent |
| 09/05/2001 | EP0632809B1 Quinuclidine derivatives as substance p antagonists |
| 09/05/2001 | EP0630374B1 Imidazole, triazole and tetrazole derivatives |
| 09/05/2001 | CN1311818A Neurotrophic factors |
| 09/05/2001 | CN1311789A Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
| 09/05/2001 | CN1311785A Tetrahydroquinoline derivatives as glycine antagonists |
| 09/05/2001 | CN1311779A Succinoylamino lactams as inhibitors and as A beta protein production |
| 09/05/2001 | CN1311777A High affinity ligands for nociceptin receptor ORL-1 |
| 09/05/2001 | CN1311770A Derivatives of alpha-amino acid phenyl ester |
| 09/05/2001 | CN1311682A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol |
| 09/05/2001 | CN1311681A combination therepy for treatment of refractory depression |
| 09/05/2001 | CN1311680A Pyrrolo [2,3d] pyrimidine compositions and their use |
| 09/05/2001 | CN1311676A Compound that inhibit the binding of integrins to their receptors |
| 09/05/2001 | CN1311670A Cholinergic agents in the treatment of presbyopia |
| 09/05/2001 | CN1311629A Inhibitors of transcription factor NF-KB |
| 09/05/2001 | CN1311216A New polypeptide-human microtubulin 11 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311209A New polypeptide-human ataxia-telangiectatic mutation protein 9 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311022A Quick action health preserving liquid for stopping smoking and narcotic drugs |
| 09/05/2001 | CN1311014A Chinese herbal granule for curing headache and its preparing method |
| 09/05/2001 | CN1311004A Oral liquor for tonifying the brain and replenishing wisdom |
| 09/05/2001 | CN1070490C 吲哚衍生物 Indole derivatives |
| 09/04/2001 | USRE37355 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
| 09/04/2001 | US6285537 Stress-follower circuit configuration |
| 09/04/2001 | US6284896 Abeo-ergoline derivatives as 5HT1A ligands |
| 09/04/2001 | US6284882 Myostatin gene promoter and inhibition of activation thereof |
| 09/04/2001 | US6284785 1-arenesulfonyl-2-aryl-pyrrolidine and pyridine derivatives |
| 09/04/2001 | US6284779 Nervous system disorders |
| 09/04/2001 | US6284778 Neurotrophic agent |
| 09/04/2001 | US6284776 Method for treating diseased-related or drug-induced dyskinesias |
| 09/04/2001 | US6284774 4-Benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists |
| 09/04/2001 | US6284771 Administering an heterocycle nitrogen compound |
| 09/04/2001 | US6284770 Administering serotonine receptor antagonist |
| 09/04/2001 | US6284769 Nonpeptide kappa opioid receptor antagonists |
| 09/04/2001 | US6284766 9H-pyrimido [4,5-b] indole derivatives: CRF1 specific ligands |
| 09/04/2001 | US6284761 1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands |
| 09/04/2001 | US6284760 Method of treating schizophrenia, depression and other neurological conditions |
| 09/04/2001 | US6284757 Antiserotinone agent |
| 09/04/2001 | US6284731 Polypeptides |
| 09/04/2001 | US6284540 Neuronal trophic support and cell differentiation by introducing nucleotide sequence |
| 09/04/2001 | US6284515 Signal recognition particle polypeptides and polynucleotides |
| 09/04/2001 | US6284464 Inhibition of binding of Hox and homeodomain-containing proteins and uses thereof |
| 09/04/2001 | US6284272 Pharmaceutical compositions containing an effervescent acid-base couple |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 09/04/2001 | US6284243 Physiologically functional food having brain function-improving, learning ability-enhancing, and memory-enhancing functions |
| 09/04/2001 | CA2125103C 6-piperazinyl-1h-pyrazolo¬3,4-b|pyridine-3-carboxylic acids, esters, amides and related compounds, a process for their preparation and their use as medicaments |
| 09/04/2001 | CA2045359C 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines |
| 09/04/2001 | CA2037410C Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 08/30/2001 | WO2001063295A2 Dpi-6, a therapeutic biomarker in neurological disorders |
| 08/30/2001 | WO2001063293A2 Diagnosis and treatment of schizophrenia |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062916A1 Novel armadillo repeat-containing protein alex1 |
| 08/30/2001 | WO2001062913A1 Vertebrate globin |
| 08/30/2001 | WO2001062901A2 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 08/30/2001 | WO2001062897A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines |
| 08/30/2001 | WO2001062801A2 Humanized antibodies that sequester amyloid beta peptide |
| 08/30/2001 | WO2001062799A2 Method for inhibiting angiogenesis using molecules that enhance plasmin activity |
| 08/30/2001 | WO2001062795A1 COMPOUNDS RELATED TO OR DERIVED FROM GFRα4 AND THEIR USE |
| 08/30/2001 | WO2001062793A2 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062785A2 Protein and gene and their use for diagnosis and treatment of schizophrenia |
| 08/30/2001 | WO2001062775A2 Novel antiarrhythmic peptides |